| Issue Date | Title | Author(s) |
| 5-Jul-2021 | CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort | Liu, Jianying; Yu, Wenjuan; Gao, Fei; Qi, Shuangshuang; Du, Juan; Ma, Xiaolong; Zhang, Yan; Zheng, Jie; Su, Jing |
| 2-Nov-2023 | Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF) | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Suo, Shanshan; Yu, Wenjuan; Jin, Jie |
| 2024 | Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yin, Hewen; Suo, Shanshan; Yu, Wenjuan; Jin, Jie |
| 2017 | Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases | Su, Jing; Yu, Wenjuan; Liu, Jianying; Zheng, Jie; Huang, Sixia; Wang, Yuchen; Qi, Shuangshuang; Ma, Xiaolong; Chen, Jian; Zhang, Yan |
| 2012 | KLF6/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: An exon involved mechanism | Gong, Miaozi; Yu, Wenjuan; Pei, Fei; You, Jiangfeng; Cui, Xianglin; McNutt, Michael A.; Li, Gang; Zheng, Jie |
| 2013 | A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain | Yu, Wenjuan; Wang, Leiming; Wang, Yuewei; Xu, Xiaoyan; Zou, Pengcheng; Gong, Miaozi; Zheng, Jie; You, Jiangfeng; Wang, Hua; Mei, Fang; Pei, Fei |
| 2012 | Phosphoprotein associated with glycosphingolipid microdomains 1 inhibits the proliferation and invasion of human prostate cancer cells in vitro through suppression of Ras activation | Yu, Wenjuan; Wang, Yuewei; Gong, Miaozi; Pei, Fei; Zheng, Jie |
| Oct-2022 | Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yu, Wenjuan; Jin, Jie |
| 2008 | Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype | Mi, Yingchang; Xue, Yanping; Yu, Wenjuan; Liu, Shihe; Zhao, Yaozhong; Meng, Qingxiang; Bian, Shougeng; Wang, Jianxiang |
| Jun-2022 | Venetoclax plus 3+7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial | Wang, Huafeng; Mao, Liping; Yang, Min; Qian, Pengxu; Lu, Huan; Tong, Hongyan; Xie, Wanzhuo; Zhou, De; Huang, Xin; Wang, Yungui; Xu, Gaixiang; Lu, Ying; Wei, Juying; Mai, Wenyuan; Ye, Xiujin; Meng, Haitao; Shen, Yaojia; Huang, Jian; Yu, Wenjuan; Sun, Jie; Sheng, Jianpeng; Yan, Xiaoyan; Jin, Jie; Zhu, Hong-Hu |
